Ustekinumab (Stelara®) received FDA approval in September 2013 for a new indication of the treatment of adults with active psoriatic arthritis (PsA), alone or in combination with methotrexate. Already indicated…
…registry of patients initiated on biologic therapy in the UK with a parallel comparison cohort of non-TNF inhibitor treated patients enrolled. Participants undergo a comprehensive baseline assessment and follow-up assessments…
Severe Medial Compartment Knee OA The efficacy of glucosamine and/or chondroitins in knee osteoarthritis (OA) has been controversial. A recent large, randomized, multicenter trial (the GAIT trial) found no symptomatic…
…Editorial Comment The results of these two studies are quite astonishing and question the use of a procedure that has become commonplace, albeit with little prior rigorous evaluation. Prior studies…
…regulated genes such as dorsomycin, cecropin, diptercin, etc, all which have anti-microbial properties. The novel features of this receptor complex prompted work on the identification of a similar complex in…
…and by 40% at the 40µg dose when compared to placebo. Total-body bone mineral increased by 2 to 4 percentage points for both groups receiving PTH compared to the group…
